Detalles de la búsqueda
1.
Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma.
N Engl J Med
; 390(23): 2143-2155, 2024 Jun 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38899693
2.
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network.
Lancet
; 403(10441): 2293-2306, 2024 May 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38705160
3.
HIV Prevention Among Men Who Have Sex With Men: Tenofovir Alafenamide Combination Preexposure Prophylaxis Versus Placebo.
J Infect Dis
; 229(4): 1123-1130, 2024 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37969014
4.
Extended Postexposure Protection Against Vaginal Simian/Human Immunodeficiency Virus Infection With Tenofovir Alafenamide Fumarate/Elvitegravir Inserts in Macaques.
J Infect Dis
; 229(6): 1791-1795, 2024 Jun 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38134382
5.
Global HIV Incidence Analysis and Implications for Affordability Using Long-Acting Cabotegravir Versus Continuous and Event-Driven Oral Preexposure Prophylaxis.
Clin Infect Dis
; 78(2): 386-394, 2024 02 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37665213
6.
Weight Changes and Adverse Pregnancy Outcomes With Dolutegravir- and Tenofovir Alafenamide Fumarate-Containing Antiretroviral Treatment Regimens During Pregnancy and Postpartum.
Clin Infect Dis
; 78(6): 1617-1628, 2024 Jun 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38180851
7.
Real-life data of immune recovery using bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed people living with HIV. Results at 48-96â weeks of RETROBIC Study.
J Antimicrob Chemother
; 79(3): 595-607, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38267266
8.
Integrase strand transfer inhibitor resistance mediated by R263K plus E157Q in a patient with HIV infection treated with bictegravir/tenofovir alafenamide/emtricitabine: case report and review of the literature.
J Antimicrob Chemother
; 79(5): 1153-1156, 2024 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38558010
9.
Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort.
J Antimicrob Chemother
; 79(6): 1279-1288, 2024 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38581349
10.
Twelve-month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV: Real-world insights from BICSTaR cohorts.
HIV Med
; 25(4): 440-453, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38148567
11.
The CLL12 trial: ibrutinib vs placebo in treatment-naïve, early-stage chronic lymphocytic leukemia.
Blood
; 139(2): 177-187, 2022 01 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34758069
12.
Hepatitis B relapse after entecavir or tenofovir alafenamide cessation under anti-viral prophylaxis for cancer chemotherapy.
Virol J
; 21(1): 79, 2024 04 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38570803
13.
Tenofovir alafenamide or tenofovir disoproxil fumarate in pregnancy to prevent HBV transmission: Maternal ALT trajectory and infant outcomes.
Liver Int
; 44(6): 1422-1434, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38456620
14.
Impact of targeted agents on survival of chronic lymphocytic leukemia patients age >65 relative to age- and sex-matched population.
Am J Hematol
; 99(3): 480-483, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38100222
15.
Safety and adherence of bictegravir/emtricitabine/tenofovir alafenamide for HIV post-exposure prophylaxis among adults in Guiyang China: a prospective cohort study.
BMC Infect Dis
; 24(1): 565, 2024 Jun 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38844855
16.
Development of tenofovir monobenzyl ester phosphonoamidate prodrugs with improved anti-hepatitis B virus activity and intrahepatic tenofovir enrichment.
Bioorg Med Chem
; 99: 117607, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38246114
17.
Pharmacokinetics of tenofovir alafenamide, emtricitabine, and dolutegravir in a patient on peritoneal dialysis.
AIDS Res Ther
; 21(1): 34, 2024 May 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38773606
18.
Long-Term Outcomes after Switching to Tenofovir Alafenamide in Patients with Chronic Hepatitis B.
Int J Mol Sci
; 25(4)2024 Feb 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38396921
19.
Urine Tenofovir Levels Strongly Correlate With Virologic Suppression in Patients With Human Immunodeficiency Virus on Tenofovir Alafenamide-Based Antiretroviral Therapy.
Clin Infect Dis
; 76(5): 930-933, 2023 03 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36253952
20.
Weight and Metabolic Changes After Switching From Tenofovir Alafenamide/Emtricitabine (FTC)+Dolutegravir (DTG), Tenofovir Disoproxil Fumarate (TDF)/FTC + DTG, and TDF/FTC/Efavirenz to TDF/Lamivudine/DTG.
Clin Infect Dis
; 76(8): 1492-1495, 2023 04 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36519389